Filgrastim Injection IP

600 INR/Pack

Get a Price/Quote

Product Details:

Dosage Form Injection
Indication Used for the treatment of neutropenia, to stimulate the production of white blood cells during chemotherapy, bone marrow transplantation, and other conditions leading to low neutrophil counts.
Salt Composition Filgrastim
Enzyme Types Recombinant human granulocyte colony stimulating factor (G-CSF)
Feature Sterile, preservative-free, single-use vial.
Ingredients Filgrastim (recombinant G-CSF), sterile water for injection and excipients
Application
Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Filgrastim Injection IP Price And Quantity

Minimum Order Quantity 5 Pack
Price 600 INR/Pack

Filgrastim Injection IP Product Specifications

Ingredients Filgrastim (recombinant G-CSF), sterile water for injection and excipients
Enzymatic Activity Stimulates the proliferation and differentiation of neutrophil progenitor cells.
Storage Instructions Store at 2C to 8C. Do not freeze. Protect from light.
Enzyme Types Recombinant human granulocyte colony stimulating factor (G-CSF)
Fermentation Smell Odorless
Ph Level Approximately 7.4
Temperature Needed For Fermentation Not applicable (recombinant technology; not traditional microbial fermentation)
Physical Color/Texture Clear, colorless sterile solution
Salt Composition Filgrastim
Feature Sterile, preservative-free, single-use vial.
Indication Used for the treatment of neutropenia, to stimulate the production of white blood cells during chemotherapy, bone marrow transplantation, and other conditions leading to low neutrophil counts.
Dosage Form Injection
Shelf Life 24 months

Filgrastim Injection IP Trade Information

Payment Terms Cash Advance (CA), Cash in Advance (CID)
Supply Ability 1000 Pack Per Week
Delivery Time 4 Days
Main Domestic Market All India, South India, Central India, West India, North India, East India, Gujarat, Karnataka, Kerala, Lakshadweep, Mizoram, Meghalaya, Manipur, Andhra Pradesh, Bihar, Chandigarh, Daman and Diu, Goa, Jharkhand, Odisha, Punjab, Assam, Delhi, Dadra and Nagar Haveli, Andaman and Nicobar Islands, Arunachal Pradesh, Chhattisgarh, Haryana, Himachal Pradesh, Jammu and Kashmir, Madhya Pradesh, Maharashtra, Nagaland, Rajasthan, Sikkim, Tamil Nadu, Telangana, Tripura, Pondicherry, Uttar Pradesh, Uttarakhand, West Bengal

Product Description

Peg Frastim 6mg Injection is used to prevent infections after chemotherapy. It is a growth factor that stimulates the bone marrow to produce white blood cells. These cells protect the body against infections.

What is Filgrastim Injection IP used for?Filgrastim Injection IP is a medication used to stimulate the production of white blood cells in patients undergoing chemotherapy, bone marrow transplantation, or certain other medical procedures that may cause a decrease in white blood cell counts.
How does Filgrastim Injection IP work?Filgrastim is a synthetic form of a naturally occurring protein called granulocyte colony-stimulating factor (G-CSF). It works by stimulating the bone marrow to produce more white blood cells, which helps to prevent infections in patients with weakened immune systems.
How is Filgrastim Injection IP administered?Filgrastim Injection IP is typically administered as a subcutaneous (under the skin) injection. The dosage and frequency of administration will depend on the specific medical condition being treated and your individual response to the medication.
What are the common side effects of Filgrastim Injection IP?Common side effects of Filgrastim Injection IP may include bone pain, headache, fever, nausea, vomiting, diarrhea, and injection site reactions (such as redness, swelling, or pain at the injection site). These side effects are usually temporary and mild.
Are there any precautions or considerations before using Filgrastim Injection IP?Before using Filgrastim Injection IP, inform your healthcare provider if you have any allergies, medical conditions, or if you are pregnant or breastfeeding. Also, inform them about any medications you are taking, as certain drugs may interact with Filgrastim.
What should I do if I miss a dose of Filgrastim Injection IP?If you miss a dose of Filgrastim Injection IP, contact your healthcare provider for instructions. Do not double the dose to make up for a missed one.
How long will I need to use Filgrastim Injection IP?The duration of treatment with Filgrastim Injection IP will depend on the specific medical condition being treated and your individual response to the medication. Your healthcare provider will determine the appropriate length of treatment for you.

Powerful Support Against Neutropenia

Filgrastim Injection IP is specifically designed to manage neutropenia, stimulating the production of white blood cells essential for defense against infections. It is particularly beneficial for patients experiencing low neutrophil counts due to chemotherapy, bone marrow transplantation, or similar therapies, thereby reducing the risk of potentially severe infections.

Advanced Recombinant Technology

This product leverages recombinant DNA technology, utilizing E. coli as the genetic source to synthesize a high-purity, active form of human granulocyte colony stimulating factor (G-CSF). This ensures consistent quality, safety, and effectiveness, making it suitable for the rigorous demands of modern clinical practice.

Ease of Use & Superior Safety

Filgrastim Injection IP arrives as a ready-to-use, clear, colorless, and odorless sterile solution. Housed in a secure glass vial, it does not require reconstitution, streamlining the administration process in hospital settings. Strict storage and handling protocols guarantee maximum efficacy throughout its extended shelf life.

FAQs of Filgrastim Injection IP:

Q: How is Filgrastim Injection IP administered?

A: Filgrastim Injection IP is administered via subcutaneous or intravenous injection by trained healthcare professionals in a hospital setting. Self-administration is not permitted due to the need for precise dosing and monitoring.

Q: What are the primary uses of Filgrastim Injection IP?

A: This medication is indicated for the treatment of neutropenia, a condition characterized by low levels of neutrophils (a type of white blood cell), especially in patients undergoing chemotherapy or bone marrow transplantation. It helps to reduce infection risk by boosting white cell production.

Q: When should Filgrastim Injection IP be used?

A: Filgrastim is used during periods of significant neutropenia, most commonly during or following treatments that suppress bone marrow function, such as chemotherapy or stem cell transplantation, and only upon the guidance of a licensed physician.

Q: Where should Filgrastim Injection IP be stored?

A: Store Filgrastim Injection IP in its original packaging at 2C to 8C, away from light. Do not freeze the solution, and always check the expiry date and batch number as noted on the packaging before use.

Q: What is the process and benefit of using Filgrastim Injection IP?

A: Once administered, Filgrastim stimulates the proliferation and differentiation of neutrophil progenitor cells in the bone marrow, effectively increasing circulating neutrophil counts. This reduces the duration and severity of neutropenia, lowering the risk of severe infections in patients.

Q: Is reconstitution required before administration?

A: No, Filgrastim Injection IP comes as a ready-to-use sterile solution and does not require any reconstitution or dilution before administration.

Q: What precautions should be observed when handling Filgrastim Injection IP?

A: This injection is strictly for hospital use, to be administered by qualified personnel. It should not be used for self-administration. Always inspect the vial for particulate matter or discoloration before use and dispose of any unused solution appropriately.